93 related articles for article (PubMed ID: 10319748)
41. In vivo study of a technetium labelled anti-EGFr MoAB.
Scopinaro F; De Vincentis G; Banci M; Schillaci O; Di Loreto M; Danieli R; Ierardi M; De Paola AM; Gianni W; Massa R
Anticancer Res; 1997; 17(3B):1761-5. PubMed ID: 9179231
[TBL] [Abstract][Full Text] [Related]
42. Immunoscintigraphy with 99mTc-labelled anti-CEA monoclonal antibody in colorectal carcinoma.
Vieira MR; Rodrigues M; Salgado L; Santos R; de Almeida JC; Manoel LO; de Almeida JM
Eur J Surg Oncol; 1993 Jun; 19(3):294-9. PubMed ID: 8314389
[TBL] [Abstract][Full Text] [Related]
43. Dual-isotope SPECT using simultaneous acquisition of 99mTc and 123I radioisotopes: a double-injection technique for peri-ictal functional neuroimaging.
Brinkmann BH; O'Connor MK; O'Brien TJ; Mullan BP; So EL; Robb RA
J Nucl Med; 1999 Apr; 40(4):677-84. PubMed ID: 10210229
[TBL] [Abstract][Full Text] [Related]
44. A pilot pharmacokinetic and immunoscintigraphic study with the technetium-99m-labeled monoclonal antibody BC-1 directed against oncofetal fibronectin in patients with brain tumors.
Mariani G; Lasku A; Pau A; Villa G; Motta C; Calcagno G; Taddei GZ; Castellani P; Syrigos K; Dorcaratto A; Epenetos AA; Zardi L; Viale GA
Cancer; 1997 Dec; 80(12 Suppl):2484-9. PubMed ID: 9406699
[TBL] [Abstract][Full Text] [Related]
45. Imaging of colorectal carcinoma with technetium-99m radiolabeled Fab' fragments.
Podoloff DA; Patt YZ; Curley SA; Kim EE; Bhadkamkar VA; Smith RE
Semin Nucl Med; 1993 Apr; 23(2):89-98. PubMed ID: 8511605
[TBL] [Abstract][Full Text] [Related]
46. Dual-isotope protocol for indium-111 capromab pendetide monoclonal antibody imaging.
Kelty NL; Holder LE; Khan SH
J Nucl Med Technol; 1998 Sep; 26(3):174-7. PubMed ID: 9755436
[TBL] [Abstract][Full Text] [Related]
47. Pharmacological evaluation of humanized anti-epidermal growth factor receptor, monoclonal antibody h-R3, in patients with advanced epithelial-derived cancer.
Crombet T; Torres L; Neninger E; Catalá M; Solano ME; Perera A; Torres O; Iznaga N; Torres F; Pérez R; Lage A
J Immunother; 2003; 26(2):139-48. PubMed ID: 12616105
[TBL] [Abstract][Full Text] [Related]
48. Lymphoma imaging with a new technetium-99m labelled antibody, LL2.
Murthy S; Sharkey RM; Goldenberg DM; Lee RE; Pinsky CM; Hansen HJ; Burger K; Swayne LC
Eur J Nucl Med; 1992; 19(6):394-401. PubMed ID: 1618230
[TBL] [Abstract][Full Text] [Related]
49. Indium-111-labeled anti-EGFr-425 scintigraphy in the detection of malignant gliomas.
Dadparvar S; Krishna L; Miyamoto C; Brady LW; Brown SJ; Bender H; Slizofski WJ; Eshleman J; Chevres A; Woo DV
Cancer; 1994 Feb; 73(3 Suppl):884-9. PubMed ID: 8306274
[TBL] [Abstract][Full Text] [Related]
50. 99mTc-CD19 monoclonal antibody is not useful for imaging of B cell non-Hodgkin's lymphoma.
Vervoordeldonk SF; Heikens J; Goedemans WT; Merle PA; von dem Borne AE; van Royen EA; Slaper-Cortenbach IC; van Oers RH
Cancer Immunol Immunother; 1996 Jun; 42(5):291-6. PubMed ID: 8706051
[TBL] [Abstract][Full Text] [Related]
51. Radiotoxicity of h-R3 monoclonal antibody labeled with 188Re administered intracerebrally in rats.
Gonzalez B; Casaco A; Alvarez P; Leon M; Arteaga M; Leon A; Santana E; Bada A; Figueredo R; Hernández R; Iznaga-Escobar N; González F; Perez R
Hum Exp Toxicol; 2000 Dec; 19(12):684-92. PubMed ID: 11291740
[TBL] [Abstract][Full Text] [Related]
52. Diagnostic value of ocular melanoma immunoscintigraphy.
Janković Z; Pucar D; Jauković L; Ajdinović B
J BUON; 2006; 11(3):347-50. PubMed ID: 17309161
[TBL] [Abstract][Full Text] [Related]
53. Monoclonal anti-epidermal growth factor receptor (ior EGF/r3) antibody pharmacokinetic studies on nude mice I: a radio-receptor analysis applied to drug serum quantification.
Fernandez-Sánchez E; Ducongé J; Castillo R; Garcia I; Beausoleil I; Macías A
J Pharm Pharmacol; 2002 Jan; 54(1):59-64. PubMed ID: 11829130
[TBL] [Abstract][Full Text] [Related]
54. Immunoscintigraphy of infections using 123I and 99mTc-labeled monoclonal antibodies. Advanced experiences in 230 patients.
Seybold K; Frey LD; Locher J
Angiology; 1992 Feb; 43(2):85-90. PubMed ID: 1536479
[TBL] [Abstract][Full Text] [Related]
55. Imaging acute appendicitis: an opportunity for nuclear medicine in the surgical emergency room.
Oyen WJ; Boerman OC; Corstens FH
J Nucl Med; 2000 Mar; 41(3):456-8. PubMed ID: 10716318
[No Abstract] [Full Text] [Related]
56. 99mTc-Labeled Small Peptides as Diagnostic Radiopharmaceuticals.
Liu S; Edwards DS
Chem Rev; 1999 Sep; 99(9):2235-68. PubMed ID: 11749481
[No Abstract] [Full Text] [Related]
57. MALIGNANT EPITHELIAL TUMORS OF THE NECK OF UNKNOWN ORIGIN.
McWhorter JE
Ann Surg; 1929 Jul; 90(1):1-14. PubMed ID: 17866117
[No Abstract] [Full Text] [Related]
58. EGFR, the Lazarus target for precision oncology in glioblastoma.
Lin B; Ziebro J; Smithberger E; Skinner KR; Zhao E; Cloughesy TF; Binder ZA; O'Rourke DM; Nathanson DA; Furnari FB; Miller CR
Neuro Oncol; 2022 Dec; 24(12):2035-2062. PubMed ID: 36125064
[TBL] [Abstract][Full Text] [Related]
59. Immunohistochemical Characterization of Three Monoclonal Antibodies Raised against the Epidermal Growth Factor and Its Receptor in Non-Small-Cell Lung Cancer: Their Potential Use in the Selection of Patients for Immunotherapy.
Rengifo CE; Blanco R; Blanco D; Cedeño M; Frómeta M; Calzado ER
J Biomark; 2013; 2013():627845. PubMed ID: 26317020
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
